Relapsing polychondritis: reversible airway obstruction is not always asthma

Michael J Segel1, Simon Godfrey, Neville Berkman

  • 1Institute of Pulmonology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Insights

Relapsing polychondritis (RP) can initially mimic asthma, leading to delayed diagnosis. Early immunosuppressive treatment may prevent severe airway damage in this rare cartilaginous disease.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Rare Diseases

Background:

  • Relapsing polychondritis (RP) is a rare autoimmune condition affecting cartilage.
  • Respiratory tract involvement in RP frequently leads to significant morbidity and mortality.

Observation:

  • A patient presented with initial symptoms consistent with asthma.
  • The patient later developed characteristic signs and symptoms of relapsing polychondritis.
  • Tracheobronchomalacia developed, requiring airway stenting for support.

Findings:

  • Airway obstruction in early RP may be attributed to inflammation.
  • The case highlights the potential for RP to initially manifest with asthma-like symptoms.

Implications:

  • Early diagnosis and aggressive immunosuppressive therapy for RP are crucial.
  • Prompt treatment may prevent irreversible damage to cartilage and airway collapse.
  • This case underscores the importance of considering RP in patients with persistent airway issues.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: